Recombinant Human EG-VEGF/PROK1 His

Hersteller Cell Sciences
Typ Proteins
Specific against Human
Menge 50 ug
Host Mouse
ArtNr CS-CRE129B
eClass 6.1 34160400
eClass 9.0 42020190
Human EG-VEGF (Endocrine-gland-derived vascular endothelial growth factor) induces proliferation, migration and fenestration in capillary endothelial cells derived from endocrine glands. Recombinant EG-VEGF consists of 86 amino acid residues.
Lyophilized from a 0.2 um sterile filtered solution in PBS
Centrifuge vial prior to opening . Add sterile PBS to the vial to fully solubilize the protein to a concentration of 0.1-1.0 mg/ml, containing 0.1% BSA. Please note that the addition of any carrier protein into this product may produce unwanted endotoxin. This depends upon the particular application employed.
Storage and Stability
Lyophilized protein is stable for 1 year at -20C to -80C. Reconstituted protein is stable for 1 week at 2-4C or for 3 months in working aliquots at -20C. Avoid repeated freeze-thaw cycles .
Mouse myeloma cell line
Molecular Weight
9.5 kDa
> 98% as determined by SDS-PAGE and HPLC analyses
Protein Accession No
Endotoxin Level
< 0.1 ng/ug of EG-VEGF
Biological Activity
Determined by the dose-dependent stimulation of the proliferation of HUVEC using a concentration range of 1-5 ng/ml.
Menge: 50 ug
Lieferbar: Out of stock
nicht lieferbar

fragen Sie nach einem alternativen Produkt

Fragen zum Produkt?